tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market
RYTM
Rhythm Pharmaceuticals
RESEARCH TOOLSreports

Rhythm Pharmaceuticals (RYTM) Stock News & Sentiment

Compare
564 Followers
Promising Clinical Results and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Promising Clinical Results and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
1d ago
RYTM
Promising Phase 2 Results for Rhythm Pharmaceuticals’ Setmelanotide in Prader-Willi Syndrome Boost Buy Rating
Premium
Ratings
Promising Phase 2 Results for Rhythm Pharmaceuticals’ Setmelanotide in Prader-Willi Syndrome Boost Buy Rating
2d ago
RYTM
Positive Phase 2 Trial Results Boost Rhythm Pharmaceuticals’ Outlook and Price Target
Premium
Ratings
Positive Phase 2 Trial Results Boost Rhythm Pharmaceuticals’ Outlook and Price Target
2d ago
RYTM
Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
2d ago
8K
RYTM
Positive Outlook for Rhythm Pharmaceuticals Despite FDA Review Delay and Financial Shortfall
Premium
Ratings
Positive Outlook for Rhythm Pharmaceuticals Despite FDA Review Delay and Financial Shortfall
1M ago
RYTM
Rhythm Pharmaceuticals Faces FDA Review Extension
Premium
Company Announcements
Rhythm Pharmaceuticals Faces FDA Review Extension
1M ago
8K
RYTM
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Optimism
Premium
Company Announcements
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Optimism
1M ago
RYTM
More RYTM News >

RYTM News on the Web

TD Cowen Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM)
TipRanks News
Neutral
Rhythm Pharmaceuticals to Reveal Preliminary Phase 2 Results for Setmelanotide in Prader-Willi Syndrome
Market Chameleon
Neutral
Setmelanotide Shows Promising Early Results in Prader-Willi Syndrome: Phase 2 Data Signal Efficacy and Support Advancement
Market Chameleon
Neutral
Rhythm Pharma To Present Preliminary Phase 2 Data Of Setmelanotide In Prader-Willi Syndrome Today
rttnews
Neutral
Why Rhythm Pharmaceuticals, Inc.’s (RYTM) Stock Is Up 11.81%
AAII
Neutral
Why Rhythm Pharmaceuticals, Inc.’s (RYTM) Stock Is Up 5.56%
AAII
Neutral
Rythm Pharmaceuticals' (RYTM) Chief Technical Officer Sells 9,748 Shares for $1.1 Million
The Motley Fool
Neutral
Oppenheimer downgrades Rhythm Pharmaceuticals (RYTM) to a Hold
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
RYTM
Sector Average
Media Buzz
This Week5 articles
Weekly Average1.25 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RYTM’s Media Buzz Sentiment?
5 articles about RYTM were published this week. In an average week, 1.25 articles are published.
    What is RYTM’s weekly average amount of articles?
    In an average week, 1.25 articles about RYTM are published.
      What is RYTM’s News Sentiment?
      59% of articles about RYTM were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        XCURExicure
        SCLPScancell Holdings
        WVEWave Life Sciences
        STAAStaar Surgical
        KYMRKymera Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week